Purchase Order 75N95024P00242
Award Date
4/18/24
Potential Completion Date
4/22/25
Potential Value
$20K
Federal Agency
National Institute on Drug Abuse
Awardee
Transnetyx, Inc.
Ultimate Awardee
Not listed
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), part of the U.S. Department of Health and Human Services, to Transnetyx, Inc. The contract, valued at $24,999.00, is for automated genotyping services to support research examining the behavior and cellular mechanisms of learning in addiction. Transnetyx, a for-profit organization, provides a range of genomic services to federal agencies, including DNA extraction, gene analysis, and...
This firm-fixed-price purchase order, valued at $24,487.45, was awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Transnetyx, Inc., a for-profit organization that provides automated genotyping services to support biomedical research. The contract, which has no set-aside designation, is for genotyping testing services to support NIDA's research initiatives. Transnetyx has held numerous federal contracts to provide genomic...
This is a $15,000 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse, a civilian agency within the Department of Health and Human Services, to Transnetyx, Inc., a for-profit organization headquartered in Cordova, Tennessee. The contract is not set aside and has a completion date of February 19, 2026. Transnetyx is a provider of automated genotyping, DNA extraction, multi-gene analysis, and bioinformatics services primarily for biomedical research purposes,...
This is a firm fixed price, $15,000 contract award to Transnetyx, Inc. by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse for genotyping services during fiscal year 2019. The contract has no set-aside designation and was completed on May 14, 2020. Transnetyx, Inc. is a for-profit organization that provides DNA extraction, multi-gene analysis, bioinformatics, and genotyping services to federal agencies, particularly HHS and...
This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Transnetyx, Inc., a for-profit organization that provides automated genotyping services. The $18,000.00 contract is for genotyping services to support biomedical research efforts across various federal agencies. Transnetyx has extensive experience supporting NIH institutes, including NIDA, the National Institute of Neurological...
This federal contract award to Transnetyx, Inc. is for PCR for genotyping services, with a ceiling value of $14,000 and a completion date of February 7, 2025. The contract is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services (HHS). Transnetyx, Inc., a for-profit organization specializing in automated genotyping, DNA extraction, and bioinformatics services, has extensive experience supporting...
This federal contract award to Transnetyx, Inc., a for-profit organization, is for the provision of automated genotyping services to support biomedical research across various federal agencies. The $24,000 firm fixed-price purchase order is being issued by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services (HHS). Transnetyx has extensive experience supporting research initiatives at the National Institutes of Health (NIH), including the...
Transnetyx, Inc. was awarded a firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse for $19,452.25 to provide genotype testing services. The award supports the agency's research efforts through March 2025 without a set-aside designation. As the prime contractor, Transnetyx will leverage its expertise in automated genotyping and DNA analysis to extract and sequence genes from research samples. This builds...
The Department of Health and Human Services National Institutes of Health (NIH) awarded a $100,001.70 firm fixed price purchase order to Transnetyx, Inc. to provide genotyping services. The contract has a period of performance through September 30, 2024 and does not have a set-aside designation. Transnetyx, Inc. is a for-profit organization that has held multiple prime and subcontractor awards with the NIH and other Department of Health and Human Services agencies to support biomedical...
This is a firm fixed-price delivery order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Aging to Transnetyx, Inc. The $290,259.80 contract is for genotyping support services, including DNA extraction, multi-gene analysis, bioinformatics, and genotyping. Transnetyx, a for-profit organization, has provided genetic testing and sequencing services to various HHS agencies in the past to support research on neurological...